Farr Miller & Washington’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $49.1M | Sell |
578,553
-875
| -0.2% | -$73.3K | 3.2% | 7 |
|
|
2021
Q2 | $48.3M | Buy |
579,428
+1,637
| +0.3% | +$134K | 3.16% | 8 |
|
|
2021
Q1 | $43.5M | Sell |
577,791
-3,947
| -0.7% | -$288K | 3.06% | 11 |
|
|
2020
Q4 | $39.7M | Buy |
581,738
+65,331
| +13% | +$4.25M | 3.03% | 12 |
|
|
2020
Q3 | $30.2M | Sell |
516,407
-108,987
| -17% | -$6.78M | 2.61% | 15 |
|
|
2020
Q2 | $40.6M | Sell |
625,394
-10,634
| -2% | -$670K | 3.32% | 9 |
|
|
2020
Q1 | $37.7M | Buy |
636,028
+2,144
| +0.3% | +$143K | 3.56% | 6 |
|
|
2019
Q4 | $47.1M | Buy |
633,884
+1,229
| +0.2% | +$86.3K | 3.4% | 8 |
|
|
2019
Q3 | $39.9M | Buy |
632,655
+56,547
| +10% | +$3.35M | 3.18% | 11 |
|
|
2019
Q2 | $31.4M | Buy |
576,108
+10,921
| +2% | +$588K | 2.6% | 20 |
|
|
2019
Q1 | $30.5M | Buy |
565,187
+34,797
| +7% | +$2.15M | 2.6% | 18 |
|
|
2018
Q4 | $34.8M | Sell |
530,390
-25,175
| -5% | -$1.88M | 3.31% | 7 |
|
|
2018
Q3 | $43.7M | Sell |
555,565
-501
| -0.1% | -$35.8K | 3.7% | 3 |
|
|
2018
Q2 | $35.8M | Buy |
556,066
+122,952
| +28% | +$8.1M | 3.24% | 7 |
|
|
2018
Q1 | $26.9M | Buy |
433,114
+7,212
| +2% | +$517K | 2.51% | 16 |
|
|
2017
Q4 | $30.9M | Sell |
425,902
-11,762
| -3% | -$855K | 2.76% | 12 |
|
|
2017
Q3 | $35.6M | Buy |
437,664
+4,640
| +1% | +$367K | 3.39% | 8 |
|
|
2017
Q2 | $34.8M | Buy |
433,024
+3,819
| +0.9% | +$302K | 3.41% | 5 |
|
|
2017
Q1 | $33.7M | Buy |
429,205
+112,789
| +36% | +$9M | 3.49% | 5 |
|
|
2016
Q4 | $25M | Sell |
316,416
-9,716
| -3% | -$786K | 2.69% | 13 |
|
|
2016
Q3 | $29M | Buy |
326,132
+4,403
| +1% | +$416K | 3.16% | 5 |
|
|
2016
Q2 | $30.8M | Sell |
321,729
-70,929
| -18% | -$7.07M | 3.48% | 5 |
|
|
2016
Q1 | $40.7M | Sell |
392,658
-6,449
| -2% | -$627K | 4.7% | 1 |
|
|
2015
Q4 | $39M | Buy |
399,107
+66
| +0% | +$6.46K | 4.63% | 1 |
|
|
2015
Q3 | $38.5M | Sell |
399,041
-3,201
| -0.8% | -$337K | 4.94% | 1 |
|
|
2015
Q2 | $42.2M | Buy |
402,242
+2,049
| +0.5% | +$209K | 4.88% | 1 |
|
|
2015
Q1 | $41.3M | Sell |
400,193
-886
| -0.2% | -$89.7K | 4.74% | 1 |
|
|
2014
Q4 | $38.6M | Buy |
401,079
+12,819
| +3% | +$1.13M | 4.5% | 1 |
|
|
2014
Q3 | $30.9M | Buy |
388,260
+635
| +0.2% | +$50.1K | 4.02% | 2 |
|
|
2014
Q2 | $29.2M | Buy |
387,625
+839
| +0.2% | +$63.4K | 3.75% | 3 |
|
|
2014
Q1 | $29M | Buy |
386,786
+3,202
| +0.8% | +$226K | 3.97% | 2 |
|
|
2013
Q4 | $27.5M | Buy |
383,584
+6,598
| +2% | +$424K | 3.82% | 2 |
|
|
2013
Q3 | $21.4M | Sell |
376,986
-9,215
| -2% | -$549K | 3.41% | 4 |
|
|
2013
Q2 | $22.1M | Buy |
+386,201
| New | +$22.4M | 3.6% | 3 |
|
Other funds holding CVS
Farr Miller & Washington's CVS Position: Q3 2021 in Review
Farr Miller & Washington reduced its CVS Health (CVS) stake by 0.15% in Q3 2021, selling an estimated $73.3K and leaving 578,553 shares worth $49.1M. The position accounts for 3.2% of the portfolio, ranked #7.
Farr Miller & Washington first reported a position in CVS in Q2 2013 and has held it in 34 quarters since. 2,072 funds tracked by Wall St. Rank hold CVS as of Q3 2021.
- Farr Miller & Washington held 578,553 shares of CVS Health worth $49.1M as of Q3 2021.
- Farr Miller & Washington sold 875 CVS Health shares in Q3 2021, an estimated $73.3K.
- CVS Health made up 3.2% of Farr Miller & Washington's portfolio in Q3 2021, its #7 holding.
- Farr Miller & Washington first reported a position in CVS Health in Q2 2013 and has held it in 34 quarters since.
- 2,072 funds tracked by Wall St. Rank held CVS Health as of Q3 2021.
Based on Farr Miller & Washington's 13F filing for Q3 2021, filed 15 Nov 2021.